Antibiotic slow-release preparation for local use
A local application and sustained-release preparation technology, which is applied in the field of sustained-release injections, sustained-release implants, and sustained-release preparations of antibiotics. It can solve the problems of difficult to obtain effective bactericidal concentration, increase the dose and side effects, and achieve convenient drug application. , reduce the course of treatment, and reduce the effect of drug tolerance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0107] Put 90, 80 and 70 mg polyphenylene propane (p-CPP: sebacic acid (SA) at 20: 80) copolymer into (A), (B) and (C) three Then add 100 milliliters of dichloromethane in each container, after dissolving and mixing, add 10 mg demeclocycline, 20 mg metacycline, and 30 mg polymycin respectively, and prepare 10 mg polymycin by spray drying method after shaking up again. % demeclocycline, 20% metacycline, 30% polymycin microspheres for injection. Then suspend the microspheres in physiological saline containing 15% mannitol to prepare the corresponding suspension-type sustained-release injection. The viscosity of the injection is 450cp-600cp (at 20°C-30°C). The drug release time of the slow-release injection in physiological saline in vitro is 5-15 days, and the drug release time in mice subcutaneous is about 12-20 days.
Embodiment 2
[0109] The method step of being processed into sustained-release injection is the same as that of Example 1, but the difference is that the contained antibacterial active ingredient and its weight percentage are: 2-50% demeclocycline, metacycline, polymycin, tetracycline , Doxycycline, Guanacycline, Lysinetetracycline, Hydropyrrocycline, Minocycline, Demeclocycline, Minotetracycline, Oxytetracycline, Oxytetracycline, Deoxyoxytetracycline, Doxycycline Hydrochloride oxytetracycline hydrochloride, nystatin, sulbactam, sultacillin, potassium clavulanate, ticarcillin, clavulanic acid, sulbactam sodium, tibactam, or tementine.
Embodiment 3
[0111] Put 70 mg of polylactic acid (PLGA, 75:25) with a peak molecular weight of 10,000 into three containers (A), (B) and (C) respectively, and then add 100 ml of dichloromethane to each, dissolve and mix well , add 30 mg of doxycycline, guanacycline or lysine tetracycline to three containers respectively, re-shake and prepare 30% doxycycline, guanacycline or lysine tetracycline by spray drying method microspheres for injection. The dried microspheres are suspended in physiological saline containing 1.5% sodium carboxymethylcellulose to prepare the corresponding suspension-type sustained-release injection. The viscosity of the injection is 400cp-600cp (at 20°C-30°C). The drug release time of the slow-release injection in physiological saline in vitro is 7-15 days, and the drug release time in mice subcutaneous is about 15-25 days.
PUM
Property | Measurement | Unit |
---|---|---|
glass transition temperature | aaaaa | aaaaa |
melting point | aaaaa | aaaaa |
glass transition temperature | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com